Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

EXPLAINED: 8 | Vintage Vibes

Wall Street Predict 92% Upside for This Dividend Stock: Should You Buy It Now?

While there are short-term headwinds, Merck has a bright future ahead.

Barchart · Feb 11, 2025

Merck: 4 No-Brainer Reasons to Buy This Dip

Merck & Co. stock was pummeled by 10% after its earnings release on soft forecasts, but the overreaction by the market may present a buying opportunity.

MarketBeat · Feb 10, 2025

Apple, Coca-Cola, IBM, Berkshire Hathaway: These companies are facing a DEI shareholder showdown in 2025

A fresh crop of shareholder proposals that would have once been unremarkable are now a closely watched battlefront in the war against corporate diversity and inclusion initiatives.

Fortune · Feb 10, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back.

Fortune · Feb 7, 2025

The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Fortune · Feb 5, 2025

Stock Market Today: Earnings Speak Louder Than Tariffs

Recent market reaction to Trump administration policy announcements has been "entirely normal."

Kiplinger · Feb 4, 2025

What Are Wall Street Analysts’ Target Price for Merck Stock?

Merck has considerably underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart · Feb 4, 2025

Read news from The Economist, FT, and more,
with one subscription

Stock Index Futures Muted Ahead of U.S. JOLTs Report and Fed Speak, Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

Barchart · Feb 4, 2025

Stock Index Futures Slip on Trade War Concerns, U.S. JOLTs Report and Alphabet Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.

Barchart · Feb 4, 2025

Kennedy to divest interest from HPV vaccine lawsuits - Roll Call

President Donald Trump’s Health and Human Services nominee said he will divest his interest in lawsuits against an HPV vaccine manufacturer.

Roll Call · Jan 31, 2025

Robert F. Kennedy, Jr. Retains Financial Interest In Vaccine Litigation

Robert F. Kennedy, Jr. faces potential conflicts of interest as HHS secretary nominee due to financial ties with law firms handling litigation against drug...

How RFK Jr. drove mistrust of a cancer prevention vaccine - Roll Call

President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV vaccine.

Roll Call · Jan 16, 2025

Analyst: Sell ‘Magnificent 7’ Stocks and Buy These 3 Dividend Stocks Instead

Analysts at Miramar Capital are advising investors to sell “Magnificent 7” and instead invest in lower-valuation, dividend-paying healthcare stocks.

Barchart · Jan 10, 2025

Woman Dies After Being Set On Fire In NYC Subway

Tragic death of Debrina Kawam in New York subway fire highlights safety concerns and the need for increased support services for vulnerable populations.

Breast cancer drug Lynparza reduces risk of death by 28% in patients diagnosed early, clinical trial shows

About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.

The Conversation · Dec 17, 2024

Vaccine misinformation distorts science – a biochemist explains how RFK Jr. and his lawyer’s claims threaten public health

Vaccinations provide significant protection for the public against infectious diseases and substantially reduce health care costs. Therefore, it is noteworthy that President-elect Donald Trump wants Robert F. Kennedy Jr., a leading critic of childhood vaccination, to be secretary of Health and Human Services.

Benzinga · Dec 9, 2024

Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer

Merck's ovarian cancer trial met its primary endpoint, while lymphoma trial data set the Phase 3 dose for zilovertamab vedotin at 1.75 mg/kg.

Barchart · Dec 6, 2024

How Is Merck's Stock Performance Compared to Other Pharmaceuticals Stocks?

Merck has underperformed the pharmaceuticals industry over the past year, but analysts are highly optimistic about the stock’s prospects.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Dec 2, 2024

Merck & Co Unusual Options Activity For December 02

Deep-pocketed investors have adopted a bearish approach towards Merck Co (NYSE:MRK), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRK usually suggests something big is…

Benzinga · Nov 25, 2024

Merck's WINREVAIR Achieves Results in PAH Study, Trial Ends Early on Efficacy

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, announced today positive topline results from the Phase 3 ZENITH study evaluating WINREVAIR (sotatercept-csrk) in adults with pulmonary arterial

Barchart · Nov 4, 2024

Merck & Co. Stock: Is Wall Street Bullish or Bearish?

Despite Merck & Co.’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Fortune · Oct 29, 2024

We led some of America’s largest companies. Here’s why we are voting for Harris, not Trump

'We fear a second Trump term would be bad for business and the U.S. economy.'

Kiplinger · Oct 23, 2024

Seven Stocks I Have Faith In

These companies have faced setbacks, but I'm confident their stock prices will flourish once again.

Fortune · Oct 22, 2024

Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination

More than 41,000 people in the U.S. died of pneumonia in 2022, according to the CDC.

Fortune · Oct 22, 2024

How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute

"It is integrated into everything that we do," says Merck's chief information and digital officer Dave Williams.

1 … 7 8 9 10

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.